Advanced Biomed is trading at $6.68, up 5.94%, with no clear company-specific catalyst identified. - No clear company-specific announcement or catalyst surfaced for September 25, 2026; recent coverage also reported no reliable company news around September 24. - U.S. markets were broadly higher, with reports citing easing oil-related inflation concerns and technology-sector strength; this is general risk-on context, not a confirmed cause. - The move substantially exceeded broad-market gains, and its specific catalyst remains unclear.